|
Eligibility to US clinical trials
Hi all,
First of all let me congratulate you all for being so proactive, definitly an american approach which is why more of you survive from cancer than we do in the UK. Most of you are living in the US, I am living in the UK. I am not quite sure what the ruling are regarding trials. I wish to take part (despite the required travelling) to the vaccination trials at UW. A few of you seems to have taken part, do you know if it is restricted to the US? (I wrote a email to them few days ago and have had no reply, getting impatient..)
Many thanks
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|
Linear Mode
